Multiple Sclerosis Market, [By Drug Type, (Immunosuppressant’s (Lemtrada, Ocrelizumab, Zinbryta, and Aubagio); Immunomodulators (Ampyra, Copaxone, Betaseron/Extavia, Gilneya, Avonex/Plegridy, Tysabri, Rebif, Tecifidera)); By Route of Administration (Injectable agents, Oral agents)]; and Geography - Trend, Analysis and Forecast till 2025
- Published Date: Jul 2018
- Pages: 0
- Format: PDF
- 报告ID：PM1343
- 基准年:
- Historical Data:
多发性硬化市场规模，分析 - 行业报告，2025年